Nanoparticles from Actinobacteria: A Potential Target to Antimicrobial Therapy

Area of Science:

• Nanomedicine
• Microbiology
• Antimicrobial Therapy

Background:

• Emerging infectious diseases pose a significant global health challenge, exacerbated by climate change.
• Antibiotic resistance in pathogens is a growing concern, limiting treatment options.
• Traditional treatments are often costly and ineffective against resistant strains.

Purpose of the Study:

• To review the role of nanoparticles in nanomedicine.
• To highlight the importance of actinobacteria in nanoparticle synthesis.
• To emphasize the potential of actinobacteria-mediated nanoparticles in antimicrobial therapy.

Main Methods:

• Comprehensive literature review focusing on nanoparticle synthesis and applications.
• Analysis of studies on microbial-mediated nanoparticle synthesis, particularly using actinobacteria.
• Evaluation of the antimicrobial activity of biosynthesized nanoparticles against drug-resistant pathogens.

Main Results:

• Nanoparticles have diverse applications in nanomedicine.
• Biosynthesized nanoparticles, especially those from microbial sources, exhibit eco-friendly and potent activity.
• Actinobacteria-mediated nanoparticles demonstrate significant promise for combating antimicrobial resistance.

Conclusions:

• Actinobacteria are crucial for synthesizing effective nanoparticles.
• Actinobacteria-mediated nanoparticles are a viable alternative to conventional antibiotics.
• These nanoparticles hold substantial potential for future nanomedicine applications in antimicrobial therapy.